ArticleInfectious diseases and therapy2023

Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) in Individuals Ages 12 Months and Older.

David Neveu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.